Price Alert

Anika Therapeutics Inc. (ANIK)

NASDAQ: ANIK · Real-Time Price · USD

8.80

0.16 (1.85%)

At close: Aug 15, 2025, 3:08 PM

Anika Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	53.37M	55.63M	62.37M	62.82M	68.63M	72.87M	70.65M	65.07M	79.74M	86.33M	87.78M	91.39M	90.33M	94.39M	90.98M	97.18M	94.6M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	4.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-17.77M	n/a	n/a	n/a
Other Long-Term Assets	11.56M	13.62M	11.31M	19.52M	17.57M	14.05M	18.95M	19.39M	18.13M	17.22M	18.34M	20.91M	20.39M	2.51M	23.67M	18.75M	20.29M
Receivables	21.99M	23.59M	28.36M	33.77M	32.08M	35.96M	34.68M	36.74M	30.63M	34.63M	34.17M	32.17M	29.31M	29.84M	32.35M	29.43M	26.51M
Inventory	21.34M	23.81M	39.63M	51.46M	49.41M	46.39M	43.72M	42.6M	41.32M	39.77M	37.24M	35.34M	35.23M	36.01M	35.02M	42.86M	42.72M
Other Current Assets	5.82M	10.62M	5.75M	6.94M	8.85M	8.1M	7.72M	7.79M	8.65M	8.83M	8.58M	8.96M	10.46M	8.29M	7.43M	8.3M	9.65M
Total Current Assets	102.51M	113.65M	136.11M	155M	158.96M	163.31M	156.78M	152.2M	160.33M	169.55M	167.76M	167.86M	165.32M	168.53M	165.78M	177.76M	173.47M
Property-Plant & Equipment	65.64M	64.68M	71.78M	75.45M	74.24M	74.97M	74.99M	77.62M	78.98M	78.97M	78.38M	79.69M	68.47M	68.56M	70.51M	71.39M	71.46M
Goodwill & Intangibles	9.7M	9.62M	10.74M	11.32M	11.7M	12.2M	76.02M	78.17M	80.11M	81.94M	83.27M	85.66M	88.06M	90.16M	92.97M	95.23M	97.03M
Total Long-Term Assets	88.1M	89.09M	95.3M	107.66M	104.78M	107.32M	171.38M	176.68M	178.74M	179.58M	179.99M	186.27M	176.92M	179.01M	187.15M	185.37M	188.78M
Total Assets	190.6M	202.74M	231.41M	262.65M	263.74M	270.63M	328.16M	328.88M	339.07M	349.13M	347.75M	354.12M	342.24M	347.54M	352.93M	363.13M	362.25M
Account Payables	5.28M	5.62M	6.8M	9.99M	10.02M	9.86M	7.43M	7.94M	8.95M	9.07M	8.35M	8.16M	7.44M	7.63M	7.94M	8.1M	8.68M
Deferred Revenue	n/a	n/a	n/a	77K	1.49M	1.24M	-2.05M	-2.08M	n/a	n/a	n/a	n/a	n/a	16.13M	13.3M	14.87M	11.82M
Short-Term Debt	n/a	n/a	n/a	n/a	2.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	7M	12.16M	4.19M	4.4M	6.06M	7.24M	6.79M	4.74M	7.71M	5.46M	4.91M	5.35M	10.44M	4.32M	5.98M	23.99M	24.83M
Total Current Liabilities	17.9M	23.31M	25.49M	26.12M	28.46M	31.06M	28.06M	23.46M	28.69M	27.91M	26.35M	29.43M	26.99M	29.8M	28.77M	41.37M	46.97M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	744K	1.43M	806K	407K	404K	404K	400K	401K	399K	398K	474K	587K	684K	1.26M	1.49M	1.78M	7.34M
Total Long-Term Liabilities	24.31M	25.45M	26.05M	26.2M	26.75M	27.31M	29.61M	31.41M	32.79M	35.65M	36.46M	38.54M	29.46M	30.66M	34.1M	34.96M	38.62M
Total Liabilities	42.21M	48.75M	51.54M	52.32M	55.21M	58.37M	57.67M	54.87M	61.49M	63.56M	62.81M	67.97M	56.45M	60.45M	62.87M	76.33M	85.6M
Total Debt	25.44M	25.93M	27.53M	28.08M	28.47M	29.04M	27.25M	29.86M	30.39M	30.89M	31.11M	31.61M	20.47M	19.24M	21.18M	21.6M	22.18M
Common Stock	143K	144K	147K	148K	148K	147K	146K	147K	147K	146K	146K	146K	145K	144K	144K	144K	144K
Retained Earnings	66.79M	71.67M	93.53M	123.45M	123.54M	128.05M	191.05M	197.63M	200.37M	210.72M	215.63M	219.8M	222.65M	225.58M	231.37M	230.81M	224.28M
Comprehensive Income	-6.1M	-6.78M	-5.7M	-6.42M	-6.32M	-5.94M	-6.56M	-6.16M	-6.17M	-6.44M	-7.5M	-6.65M	-5.8M	-5.72M	-5.32M	-4.85M	-5.05M
Shareholders Equity	148.4M	153.99M	179.86M	210.34M	208.54M	212.26M	270.49M	274.01M	277.59M	285.56M	284.94M	286.15M	285.79M	287.08M	290.06M	286.8M	276.66M
Total Investments	n/a	5.93M	n/a	-1	n/a	4.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a